Oxford BioDynamics is a global biotech company based in Oxford.
The firm held a 17.9% stake in the company, the filing said, and notified the issuer of the sale on 7 November.
Odey AM's stake was worth about £12.7m, as the firm has a market cap of £71.1m, according to data from Morningstar Direct.
Odey Asset Management to wind down business
Last week, Odey AM began the process of winding down its business, after the asset manager was plagued by scandal after claims of sexual assault were brought against its founder Crispin Odey.
Saba Capital calls for European Opportunities trust to increase size of tender offer
Read more on investmentweek.co.uk